SCHEMBL24184142

SCHEMBL24184142

COCCn1ncc(C)cc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ LRRK2 Q5S007 1/20 0.36
▸ CYP1A2 P05177 7/20 0.35
▸ MAOB P27338 2/20 0.35
▸ MAOA P21397 1/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HCAR3 P49019 1/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ CASP1 P29466 3/20 0.34
▸ CASP7 P55210 3/20 0.34
▸ CLK4 Q9HAZ1 3/20 0.34
▸ LMNA P02545 2/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980667 0.81 CYP1A2 (0.40) ALDH1A1CYP1A2MAOBMAOACYP3A4
SCHEMBL983515 0.81 ALDH1A1 (0.40) ALDH1A1CYP1A2MAOBMAOACYP3A4
SCHEMBL24574648 0.76 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL979238 0.73 TAS2R8 (0.32) ALDH1A1CYP1A2MAOBMAOACYP3A4
SCHEMBL981042 0.73 LRRK2 (0.34) ALDH1A1LRRK2CYP1A2MAOBMAOA
SCHEMBL15339557 0.72 CYP1A2 (0.38) ALDH1A1LRRK2CYP1A2MAOBMAOA
SCHEMBL1198707 0.71 LMNA (0.49) ALDH1A1CYP1A2HSD17B10CYP2C9MEN1
SCHEMBL22363263 0.71 LRRK2 (0.41) ALDH1A1LRRK2CYP1A2MAOBMAOA
SCHEMBL24184530 0.70 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
Hydrochloric Acid SCHEMBL31078258 0.69 IDO1 (0.43) ALDH1A1CYP1A2MAOBMAOACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348426-A1 OXOPYRROLIDINE FPR2 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2023-11-02 — — US disclosed
US-20230348426-A1 OXOPYRROLIDINE FPR2 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2023-11-02 — — US disclosed
CN-116034104-A Oxo-pyrrolidine FPR2 agonists 百时美施贵宝公司 2023-04-28 — — CN disclosed
WO-2022011084-A1 OXOPYRROLIDINE FPR2 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2022-01-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348426-A1 OXOPYRROLIDINE FPR2 AGONISTS FPR1, FPR2, FPR3 ALDH1A1 3918/4885LRRK2 2562/4885CYP1A2 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback